NCT06288659View on ClinicalTrials.gov

aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial

NARecruitingINTERVENTIONAL

Enrollment

372

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions

Aneurysmal Subarachnoid HemorrhageIntracranial Pressure Increase

Interventions

DEVICE

Intraventricular intracranial pressure monitoring

The postoperative management of ICP is guided by quantifiable Intraventricular ICP parameters. The remaining treatments are consistent with those in the control group.

Trial Locations (1)

200000

RECRUITING

Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors

lead

Huashan Hospital

OTHER